Stockreport

FDA Advisory Committee Votes in Favor of Bristol Myers Squibb's and 2seventy bio's Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy [Yahoo! Finance]

2seventy bio, Inc.  (TSVT) 
PDF and Switzerland and received a positive CHMP Opinion by the European Medicines Agency based on KarMMa-3 PRINCETON, N.J. & CAMBRIDGE, Mass., March 15, 2024 BUSINESS WIR [Read more]